Sign up USA
Proactive Investors - Run By Investors For Investors

Klondex Mines files Hollister mine report

As previously reported, the total P&P mineral reserve at Hollister was put at is 116.1k ounces of gold equivalent (AuEq) at a grade of 0.582 AuEq ounces.
Klondex Mines files Hollister mine report
As previously reported, the total P&P mineral reserve at Hollister was put at is 116.1k ounces of gold equivalent

Klondex Mines Ltd (TSE:KDX, NYSE:KLDX) told investors Monday it has now filed its technical and pre-feasibility report for the Hollister underground mine in the popular mining state of Nevada.

As previously reported, the total P&P mineral reserve at Hollister was put at is 116.1k ounces of gold equivalent (AuEq) at a grade of 0.582 AuEq ounces per ton (opt), or 19.9 AuEq grams per tonne, or g/t, contained within 199.5k tons.

In the main zone alone, the P&P reserve is 51.5k ounces AuEq at a grade of 0.658 AuEq opt (22.6 g/t) contained within 78.2k tons.

The figures did not include any results from the drilling program at Hatter Graben, which commenced in the middle of  June, targeting around 20,000 feet of drilling.

The group acquired Hollister late in 2016.

Klondex has three producing mineral properties -  the Fire Creek mine and the Midas mine and ore milling facility in Nevada, US and the True North gold mine and mill in Manitoba, Canada.

It also has  the Hollister mine and the Aurora mine and ore milling facility, also in Nevada.

 

View full INDU profile View Profile

US Market News Timeline

Newswire
March 15 2018

Related Articles

researcher filling a vial
April 23 2018
2018 is shaping up to be a crucial year for the company's drug pipeline
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
lab
March 15 2018
Amryt's lead drug candidate, AP101, is a potential treatment for epidermolysis bullosa, a rare genetic skin disorder for which there is currently no approved treatment

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use